COSCIENS Biopharma Inc. (CSCIF) Operating income 2016–2025
COSCIENS Biopharma Inc. (CSCIF) annual operating income history from SEC filings — each fiscal year as reported.
-$10.7MFY2025 · since FY2016: -$29.5M → -$10.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.7M | +41.6% |
| FY2024 | -$18.3M | -294.9% |
| FY2023 | -$4.6M | -207.2% |
| FY2022 | $4.3M | +149.8% |
| FY2021 | -$8.7M | -52.0% |
| FY2020 | -$5.7M | +44.3% |
| FY2019 | -$10.2M | -204.1% |
| FY2018 | $9.8M | +142.7% |
| FY2017 | -$23.1M | +21.7% |
| FY2016 | -$29.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice